Organisation paid for research Program year 2025 Source: CMS Open Payments

Carolina Urologic Rsrch Ctr

Neither a doctor nor a teaching hospital

Research payments

$1,281,044

112 payments

Through program year 2025, Carolina Urologic Rsrch Ctr is reported as receiving $1,281,044 in research payments, across 112 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$439,295	39
2024	Research	$349,681	29
2023	Research	$375,849	29
2022	Research	$76,765	11
2021	Research	$29,990	3
2020	Research	$9,464	1

Breakdown

Who paid Research payments · program years 2020–2025

Janssen Research & Development, LLC $1,281,044 112 payments

Studies the money was for Research payments · program years 2020–2025

A Study of TAR200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle invasive Bladder Cancer MIBC of the Bladder $904,063 73 payments
17000139Blc2002 $234,106 21 payments
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4) $133,411 17 payments
An Open Label Phase 1-2 Safety Pharmacokinetic and Proof of Concept Study of ARN 509 in patients with Progressive metastatic Castration Resistant prostate Cancer $9,464 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.